# Future Exploration Avenues

## Context
Based on the current analysis of Nova Scotia's childhood immunization coverage data, this document outlines potential areas for further research and analysis that would strengthen the decision-support framework for the PHMU vs. Pharmacy-Led program decision.

---

## 1. International Benchmarking

### Objective
Compare Nova Scotia's immunization rates against G20 countries to provide context for performance expectations.

### Data Source (from TODO.md)
- **World Bank - DPT Immunization Coverage:** https://data.worldbank.org/indicator/SH.IMM.IDPT
- **WHO Immunization Dashboard:** https://immunizationdata.who.int/

### Analysis Approach
```
1. Download G20 immunization rates (DPT, Measles, HBV)
2. Calculate NS position relative to:
   - G20 average
   - Top-performing countries (>95%)
   - Similar healthcare systems (UK, Australia, Canada national)
3. Identify gap between NS current performance and international benchmarks
```

### Expected Insight
This would answer: "How does Nova Scotia compare globally?" and provide targets based on achievable international standards.

---

## 2. Primary Care Supply Correlation

### Objective
Quantify the relationship between physician availability and immunization coverage by zone.

### Data Sources (from TODO.md)
- **World Bank - Physicians per 1,000:** https://data.worldbank.org/indicator/SH.MED.PHYS.ZS
- **CIHI Health Workforce Data**
- **Stats Canada - Table 13-10-0884-01** (Provincial physician counts)

### Analysis Approach
```
1. Obtain physician-to-population ratios by NS health zone
2. Correlate with immunization coverage rates
3. Build regression model: Coverage = f(Physicians per 1000, Zone characteristics)
4. Predict coverage improvement from adding X physicians or alternative providers
```

### Expected Insight
This would quantify: "How much does physician shortage explain the coverage gap?" and support the pharmacy-led intervention argument if non-physician providers can fill the gap.

---

## 3. Geographic/Spatial Analysis

### Objective
Map pharmacy and health facility locations against unvaccinated population clusters.

### Data Requirements
- NS pharmacy locations (NS College of Pharmacists registry)
- Health facility locations
- Census tract population data
- School locations (immunization surveillance points)

### Analysis Approach
```
1. Geocode all data points
2. Calculate service area coverage (travel time analysis)
3. Identify "vaccine deserts" - areas >30 min from immunization provider
4. Overlay with coverage rate data by school catchment
5. Model optimal PHMU deployment routes vs. pharmacy partnership zones
```

### Expected Insight
This spatial analysis would directly inform the PHMU vs. Pharmacy decision by showing:
- Where pharmacies already provide adequate coverage
- Where PHMUs would reach populations that pharmacies cannot

---

## 4. Cost-Effectiveness Analysis

### Objective
Quantify the cost per additional vaccinated child for each intervention model.

### Data Requirements
- PHMU operational costs (staffing, vehicles, equipment, per-visit overhead)
- Pharmacy reimbursement rates for pediatric immunizations
- PITP training costs per pharmacist
- Administrative/data integration costs

### Analysis Framework
```
Cost per Incremental Vaccination =
  (Total Program Cost) / (Additional Children Vaccinated)

Compare:
- PHMU: High fixed costs, variable deployment costs
- Pharmacy: Lower fixed costs, standardization investment, per-dose reimbursement
```

### Expected Insight
This would answer: "Which model provides better value per dollar spent?" - critical for budget-constrained health systems.

---

## 5. Predictive Modeling

### Objective
Forecast future coverage rates under different intervention scenarios.

### Methodology
```python
# Time series forecasting with intervention effects
from statsmodels.tsa.arima.model import ARIMA

# Model 1: Status quo (no intervention)
# Model 2: PHMU deployment in Eastern Zone
# Model 3: Province-wide pharmacy program
# Model 4: Hybrid approach

# Compare projected trajectories to 95% target
```

### Analysis Components
1. **Baseline Forecast:** Where is coverage heading without intervention?
2. **PHMU Scenario:** Estimate impact based on similar mobile unit programs
3. **Pharmacy Scenario:** Model based on adult immunization pharmacy uptake
4. **Time-to-Target:** How many years to reach 95% under each scenario?

### Expected Insight
This would provide a timeline projection for decision-makers: "When will we reach herd immunity under each approach?"

---

## 6. Demographic Deep-Dive

### Objective
Identify specific demographic factors associated with under-vaccination.

### Data Requirements
- Socioeconomic indicators by zone/community
- Immigration/new resident data (Nova Scotia has targeted immigration programs)
- Indigenous community health data (with appropriate ethics considerations)
- Urban/rural classification

### Analysis Questions
1. Do newly arrived families have lower coverage? (Medical home attachment lag)
2. Are there income-correlated patterns? (Time off work for appointments)
3. How do rural vs. urban areas differ within zones?

### Expected Insight
Understanding WHO is under-vaccinated helps design targeted interventions beyond geographic targeting.

---

## 7. Systems Dynamics Modeling

### Objective
Expand the existing Causal Loop Diagram into a quantified Stock-and-Flow model.

### Current CLD Elements
```
Family Doctor Vacancy Rate
    ↓ (+)
Unattached Pediatric Population
    ↓ (+)
Vaccine Accessibility (-)
    ↓ (+)
Immunization Coverage Rates
    ↓ (-)
Disease Outbreak Risk
    ↓ (+)
Public Health Workload
```

### Extension Approach
```
1. Add intervention "levers" (PHMU capacity, Pharmacy capacity)
2. Quantify feedback loop strengths with data
3. Simulate long-term dynamics under policy scenarios
4. Identify leverage points for maximum impact
```

### Tool Recommendation
- Stella Architect or Vensim for systems dynamics simulation
- Can visualize alongside Tableau dashboards

### Expected Insight
A systems model would show how interventions propagate through the healthcare system over time, including potential unintended consequences.

---

## 8. Provider Capacity Analysis

### Objective
Assess whether pharmacies CAN absorb pediatric immunization demand.

### Data Requirements
- Current pharmacy immunization volumes (flu, COVID, adult vaccines)
- Pharmacist workforce data
- PITP certified pharmacist count
- Pharmacy operating hours by location

### Key Questions
1. What is current pediatric immunization capacity if all pharmacies participated?
2. How many additional pharmacists need PITP training?
3. What would demand increase mean for appointment availability?

### Expected Insight
This feasibility analysis ensures the pharmacy-led option is actually achievable at scale.

---

## 9. Stakeholder Preference Research

### Objective
Understand parent preferences for immunization delivery settings.

### Methodology
- Survey research with unattached families
- Focus groups in each health zone
- Choice modeling (trade-offs between wait time, location type, provider type)

### Key Questions
1. Would parents use pharmacy immunization for children?
2. What are barriers to PHMU utilization? (Schedule, location, awareness)
3. Trust levels: Pharmacist vs. Nurse vs. Physician for infant vaccination

### Expected Insight
The "best" model from a systems efficiency perspective may fail if parents don't prefer it.

---

## 10. Real-Time Dashboard Development

### Objective
Create a live monitoring system to track intervention effectiveness.

### Components
```
1. Data Pipeline: Provincial vaccination registry → Dashboard
2. Leading Indicators:
   - Appointment bookings (PHMU or Pharmacy)
   - Follow-up completion rates
   - Geographic coverage changes
3. Lagging Indicators:
   - Quarterly coverage rate updates
   - School entry compliance rates
4. Alert System: Notify when zones fall below thresholds
```

### Technology Stack
- Tableau Server for dashboards
- Automated data refresh
- Mobile-friendly views for field teams

### Expected Insight
This would transform from periodic analysis to continuous monitoring, enabling rapid course correction.

---

## Prioritization Matrix

| Exploration | Impact | Feasibility | Priority |
|-------------|--------|-------------|----------|
| International Benchmarking | Medium | High | **Quick Win** |
| Primary Care Correlation | High | Medium | **High** |
| Geographic/Spatial Analysis | High | Medium | **High** |
| Cost-Effectiveness | Critical | Low (data gaps) | **Essential** |
| Predictive Modeling | High | Medium | **Medium** |
| Demographic Analysis | Medium | Medium | **Medium** |
| Systems Dynamics | Medium | Low | **Future** |
| Provider Capacity | High | Medium | **High** |
| Stakeholder Research | High | Low (requires IRB) | **Future** |
| Real-Time Dashboard | Medium | High | **Quick Win** |

---

## Recommended Next Steps

### Immediate (This Month)
1. Download World Bank data for G20 benchmarking
2. Complete Tableau visualizations per specifications
3. Present initial findings to stakeholders

### Short-Term (Next Quarter)
1. Conduct spatial analysis with pharmacy locations
2. Develop cost model framework
3. Build predictive baseline forecast

### Medium-Term (Next 6 Months)
1. Commission stakeholder survey research
2. Develop systems dynamics simulation
3. Pilot real-time dashboard

### Long-Term (Following Year)
1. Implement chosen intervention with monitoring
2. Conduct pre/post evaluation
3. Refine model based on real-world results

---

*This document supports the ongoing decision-support analysis for Nova Scotia Health's childhood immunization strategy.*
